Oct 01, 09:07
92% of moneycontrol users recommend buying Ipca Labs.
What's your call on Ipca Labs today?
Read 12 investor views
|Company Name||Last Price||%
|Dr Reddys Labs||3200.60||-0.88||3353.85||2420.00||54,527.29|
|Dec' 13||Sep' 13||Jun' 13||Mar' 13|
Kwality Recommended on Jun 25th 2014
Recommended price 45.00 | Peak from reco 58.00 28.89%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Ipca Labs is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 9,901.58 crore.The company has reported a standalone sales of Rs 739.81 crore and a Net Profit of Rs 137.03 crore for the quarter ended Mar 2014.
The company management includes Premchand Godha - Chairman & Managing Director, Ajit Kumar Jain - Joint Managing Director, Pranay Godha - Executive Director, Prashant Godha - Executive Director, Babulal Jain - Director, Anand T Kusre - Director, Dev Parkash Yadava - Director, Ramakanta Panda - Director, Manish Premnath - Additional Director.
It is listed on the BSE with a BSE Code of 524494 and the NSE with an NSE Code of IPCALAB.
Its Registered office is at 48, Kandivli Industrial Estate, Kandivli (West), Mumbai,Maharashtra - 400067.
Their Registrars are Link Intime India Pvt. Ltd.